Herpes Simplex 1 diagnosis by fingerstick for less than $10

The US Food and Drug Administration (FDA) gave it's clearance late last week for a novel and inexpensive testing system for the diagnosis of herpes simplex 1 virus IgG. The consumer health technology company, Theranos, Inc. said the FDA's decision provides independent validation of Theranos' patented finger stick and venous blood testing technology and the ground breaking ["]